Generalized Myasthenia Gravis

• CLINICAL_TRIALS research · 2025-11-17
  Clinical Trial Update: Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) [Phase 1]

  A phase 1 clinical trial update shows that Candid Therapeutics is conducting a Phase 1 study of Cizutamig for Generalized Myasthenia Gravis,…

• CLINICAL_TRIALS research · 2025-11-05
  Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis [Phase 3]

  Clinical trial update for a Phase 3 study evaluating intravenous efgartigimod in acetylcholine receptor antibody seronegative generalized my…

• CLINICAL_TRIALS research · 2025-09-08
  Clinical Trial Update: GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103) [EARLY_Phase 1]

  This clinical trial update reports on a Phase 1 study of GC012F Injection for refractory generalized myasthenia gravis, with the study curre…

• CLINICAL_TRIALS research · 2025-05-01
  Clinical Trial Update: Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis [Phase 2]

  Phase 2 clinical trial evaluating the efficacy and safety of tocilizumab in generalized myasthenia gravis, currently recruiting.

• CLINICAL_TRIALS research · 2025-04-10
  Clinical Trial Update: Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis [NA]

  This clinical trial entry notes a study evaluating the effects of whole-body electrical muscle stimulation during exercise in adults with Ge…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-01-06
  Clinical Trial Update: An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis [Phase 1]

  An early Phase 1 exploratory study to evaluate GC012F injection for refractory generalized myasthenia gravis, with the trial not yet recruit…

• CLINICAL_TRIALS research · 2024-10-31
  Clinical Trial Update: A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. [Phase 2, Phase 3]

  A clinical trial update indicating that B007 is being studied for Generalized Myasthenia Gravis in Phase 2/Phase 3, with recruitment ongoing…

• CLINICAL_TRIALS research · 2024-09-19
  Clinical Trial Update: Seronegative Myasthenia Gravis - Efgartigimod IV [Phase 3]

  Phase 3 clinical trial update for seronegative generalized myasthenia gravis evaluating efgartigimod IV; the study is currently recruiting.